The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study

Standard chemotherapy for soft tissue sarcomas has shown limited efficacy. Here, we sought to evaluate whether β-adrenergic receptor (β-AR) signalling contributed to the progression of sarcomas and therapy resistance. To assess the translational potential of β-adrenergic receptors, we performed immu...

Full description

Saved in:
Bibliographic Details
Published in:Sci Rep
Main Authors: Porcelli, Letizia, Garofoli, Marianna, Di Fonte, Roberta, Fucci, Livia, Volpicella, Mariateresa, Strippoli, Sabino, Guida, Michele, Azzariti, Amalia
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7320177/
https://ncbi.nlm.nih.gov/pubmed/32591592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-67342-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items